Noncardiac surgery and bleeding after percutaneous coronary intervention

Area of Science:

• Cardiology
• Interventional Cardiology
• Public Health

Background:

• Percutaneous coronary intervention (PCI) decisions, including stent type (drug-eluting vs. bare-metal), hinge on predicting late stent thrombosis risk.
• Noncardiac surgery and bleeding events increase stent thrombosis risk, often due to dual antiplatelet therapy discontinuation.

Purpose of the Study:

• To assess the incidence of noncardiac surgery and bleeding episodes in patients following PCI.
• To identify predictors for these subsequent noncardiac surgery and bleeding events.

Main Methods:

• Utilized hospital discharge coding data for adult PCI patients in New Zealand (1996-2001).
• Analyzed 5-year hospital admissions for noncardiac surgery and bleeding episodes.
• Included 11,151 patients (mean age 62 years, 30% women), primarily treated for acute coronary syndrome (73%).

Main Results:

• 26% of patients underwent noncardiac surgery within 5 years post-PCI (orthopedic, abdominal, urologic, vascular, and others).
• 8.6% experienced a bleeding episode requiring hospitalization; half were gastrointestinal, with 25% needing transfusion.
• Predictors for noncardiac surgery included advanced age, prior surgery, osteoarthritis, and peripheral vascular disease. Age and prior bleeding admission predicted subsequent bleeding.

Conclusions:

• Noncardiac surgery is a frequent occurrence after PCI.
• Bleeding events, though less common, pose significant risks.
• Interventional cardiologists must incorporate risk stratification for future noncardiac surgery and bleeding into pre-PCI decisions.